English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/37348
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury

AuthorsZaouali, Mohamed A. ; Padrissa-Altés, Susagna ; Ramalho, Fernando Silva; Arroyo, Vicente; Roselló-Catafau, Joan ; Peralta, Carmen
Issue DateApr-2008
PublisherLippincott Williams & Wilkins
CitationCritical Care Medicine 6(4): 1256-1266 (2008)
Abstract[Objective]: We examined whether pharmacologic strategies blocking angiotensin II actions protect steatotic livers against ischemia-reperfusion (I/R) injury. The effects of ischemic preconditioning (PC) on angiotensin II were also evaluated.
[Design]: Randomized and controlled animal study.
[Setting]: Experimental laboratory.
[Subjects]: Zucker rats.
[Interventions]: The following experimental groups were studied: I/R, ischemia-reperfusion + angiotensin-converting enzyme inhibitor (I/R+ACE inhibitor), ischemia-reperfusion + angiotensin II type I receptor antagonist (I/R+AT1R antagonist), ischemia-reperfusion + angiotensin II type II receptor antagonist (I/R+AT2R antagonist), and PC (5 mins of ischemia + 10 mins of reperfusion before I/R). In some of these groups, the action of bradykinin (BK) and/or peroxisome-proliferator-activated receptor-[gamma] (PPAR[gamma]) was altered pharmacologically.
[Measurements and Main Results]: I/R+ACE inhibitor, I/R+AT1R antagonist, and I/R+AT2R antagonist reduced hepatic injury in steatotic livers compared with the I/R group. PC reduced angiotensin II generation and hepatic injury in steatotic livers in comparison to I/R group. Our results revealed that I/R+ACE inhibitor, I/R+AT1R antagonist, I/R+AT2R antagonist, and PC increased BK compared with the I/R group. In addition, the effects of PC on BK and hepatic injury were abolished when angiotensin II was administered. Furthermore, administration of BK receptor antagonists to the I/R+ACE inhibitor, I/R+AT1R antagonist, I/R+AT2R antagonist, and PC groups resulted in hepatic injury similar to the I/R group, indicating that the benefits of ACE inhibitor, AT1R antagonist, AT2R antagonist, and PC were abolished when the action of BK was inhibited. Experiments aimed at investigating why BK was protective in steatotic livers indicated that BK acts as a positive regulator of PPAR[gamma]. If PPAR[gamma] action was inhibited, BK did not protect steatotic livers against hepatic injury.
[Conclusions]: Pharmacologic blockers of angiotensin II action (ACE inhibitors, AT1R antagonists, and AT2R antagonists) and PC, which reduced angiotensin II generation, increased BK generation in steatotic livers after I/R. This in turn increased PPAR[gamma] and protected this type of liver against I/R injury.
Publisher version (URL)http://dx.doi.org/10.1097/CCM.0b013e31816a023c
Appears in Collections:(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.